Atlas Trials

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

Clinical trial NCT01077570 · COMPLETED

Trial details

NCT number
NCT01077570
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2010-03-01
Primary completion
2011-02-01
Enrollment
2033

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.